Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy

Andy Andy; Robertus Bebet Prasetyo

Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy

Andy Andy * §

Contact

Robertus Bebet Prasetyo

Contact

§ Universitas Indonesia

Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy

Article Fingerprint

ReserarchID

MR47EO1

Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy Banner

Key Research Insights

Synthesized scholarly intelligence & interactive research assistant

References

16 Cites in Article

Reference Format

Otis Brawley (2012). Prostate cancer epidemiology in the United States.
M Parkin,S Whelan,J Ferlay,L Rteppo,D Thomas (2002). Cancer incidence in five continents(Volume VIII).
R Siegel,E Ward,O Brawley,A Jemal (2011). Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.
Charles Huggins,Clarence Hodges (1941). Studies on Prostatic Cancer.
Osamu Ishizuka,Osamu Nishizawa,Shuji Nishizawa,Tomoya Satoh,Masahisa Wajiki,Hideo Kiyokawa,Yoshihiro Inoue,Shinya Kobayashi,Hiroya Mizusawa,Tatsuo Nakagawa (2013). Comparison of efficacy and safety of 1- and 3-month luteinizing hormone-releasing hormone agonist depots as initial therapies for prostate cancer.
Valdo Solang,Alwin Monoarfa,Ferdinand Tjandra (2013). Profil penderita kanker prostat di RSUP Prof. Dr. R. D. Kandou Manado periode tahun 2013–2015.
N Clarke,M De Santis,A Costello,Y-H Chang,T Pickles,A Pompeo,S Bazarbashi,G Haas,M Cooperberg (2016). Global treatment patterns for late-stage prostate cancer: Updated results from ASPIRE-PCa.
B Hellerstedt,K Pienta (2009). The Current State of Hormonal Therapy for Prostate Cancer.
Patrizia Limonta,Marina Marelli,Roberta Moretti (2001). LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action.
Hein Van Poppel,Laurence Klotz (2012). Gonadotropin‐releasing hormone: An update review of the antagonists versus agonists.
P O'brien M F, Cronin A M, Fearn,B Smith,J Stasi,B Guillonneau (2009). Pretreatment prostatespecific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
D Palma,S Tyldesley,P Blood,M Liu,J Morris,T Pickles (2007). Pretreatment PSA velocity as a predictor of disease outcome following radical radiation therapy.
T Choueiri,W Xie,D' Amico,R Ross,J C Hu,M Pomerantz (2009). Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.
Fabio Cury,Daniel Hunt,Mack Roach,William Shipley,Elizabeth Gore,I‐chow Hsu,Robert Krisch,Michael Seider,Howard Sandler,Colleen Lawton (2013). Prostate‐specific antigen response after short‐term hormone therapy plus external‐beam radiotherapy and outcome in patients treated on Radiation Therapy Oncology Group study 9413.
Élcio Silva,Ubirajara Ferreira,Wagner Matheus,Eliney Faria,Gustavo Silva,Minori Saito,Auro De Souza,Azuil Laranjo,Otavio Clark,Luis Magna,Lísias Castilho,Leonardo Reis (2012). Goserelin versus leuprolide in the chemical castration of patients with prostate cancer.
Yasuhisa Fujii,Junji Yonese,Satoru Kawakami,Shinya Yamamoto,Yuhei Okubo,Iwao Fukui (2008). Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Andy Andy, Robertus Bebet Prasetyo. 2019. "Prostate-Specific Antigen Levels of Prostate Cancer Patients Three Months Following LHRH Agonist Therapy". Global Journal of Medical Research - F: Diseases GJMR-F Volume 19 (GJMR Volume 19 Issue F6).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 19 Issue F6

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmr

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-F Classification NLMC Code: WJ 752

QZ 20.5

Submission ReceivedDecember 16, 2018
Peer Review Double Blind
Handling Editor
Accepted January 1, 2019
Published January 15, 2019

Version of record

v1.2

Issue date

November 8, 2019

Language

English

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Score: 142

Country: Indonesia

Subject: Global Journal of Medical Research

Authors: Andy Andy, Robertus Bebet Prasetyo (PhD/Dr. count: 0)

View Count (all-time): 296

Total Views (Real + Logic): 1014

Total Downloads (simulated): 72

Publish Date: 2019 01, Tue

Monthly Totals (Real + Logic):

Month 1: 37 views
Month 2: 58 views
Month 3: 30 views
Month 4: 22 views
Month 5: 26 views
Month 6: 47 views
Month 7: 25 views
Month 8: 46 views
Month 9: 30 views
Month 10: 55 views
Month 11: 36 views
Month 12: 25 views
Month 13: 28 views
Month 14: 45 views
Month 15: 34 views
Month 16: 24 views
Month 17: 34 views
Month 18: 32 views
Month 19: 44 views
Month 20: 24 views
Month 21: 30 views
Month 22: 17 views
Month 23: 16 views
Month 24: 25 views
Month 25: 32 views
Month 26: 33 views
Month 27: 21 views
Month 28: 29 views
Month 29: 22 views
Month 30: 40 views
Month 31: 16 views
Month 32: 27 views
Month 33: 37 views
Month 34: 48 views
Month 35: 28 views
Month 36: 24 views
Month 37: 38 views
Month 38: 26 views
Month 39: 34 views
Month 40: 36 views
Month 41: 37 views
Month 42: 36 views
Month 43: 45 views
Month 44: 31 views
Month 45: 30 views
Month 46: 28 views
Month 47: 29 views
Month 48: 36 views
Month 49: 43 views
Month 50: 17 views
Month 51: 48 views
Month 52: 25 views
Month 53: 31 views
Month 54: 14 views
Month 55: 33 views
Month 56: 35 views
Month 57: 18 views
Month 58: 39 views
Month 59: 35 views
Month 60: 26 views
Month 61: 46 views
Month 62: 45 views
Month 63: 23 views
Month 64: 32 views
Month 65: 17 views
Month 66: 17 views
Month 67: 41 views
Month 68: 37 views
Month 69: 33 views
Month 70: 41 views
Month 71: 19 views
Month 72: 39 views
Month 73: 28 views
Month 74: 31 views
Month 75: 55 views
Month 76: 42 views
Month 77: 39 views
Month 78: 29 views
Month 79: 40 views
Month 80: 50 views
Month 81: 32 views
Month 82: 44 views
Month 83: 22 views
Month 84: 14 views
Month 85: 31 views
Month 86: 11 views
Month 87: 26 views
Month 88: 36 views
Month 89: 24 views
Month 90: 42 views
Month 91: 53 views
Month 92: 40 views
Month 93: 37 views

Total Views: 1K

Total Downloads: 72

All Trends